24 April 2025 v2026.16.1 micro_entity_frs_105_v1_1_3 filing Software false true true true false No description of principal activity 0 true xbrli:pure xbrli:shares iso4217:GBP 16406418 2025-04-24 2026-03-31 16406418 2026-03-31 16406418 core:WithinOneYear 2026-03-31 16406418 bus:RegisteredOffice 2025-04-24 2026-03-31 16406418 bus:Director1 2025-04-24 2026-03-31 16406418 1 2025-04-24 2026-03-31 16406418 countries:EnglandWales 2025-04-24 2026-03-31 16406418 bus:AuditExemptWithAccountantsReport 2025-04-24 2026-03-31 16406418 bus:PrivateLimitedCompanyLtd 2025-04-24 2026-03-31 16406418 bus:Micro-entities 2025-04-24 2026-03-31 16406418 bus:FullAccounts 2025-04-24 2026-03-31
Company registration number:
16406418
Ips Therapy Ltd
Unaudited Filleted Financial Statements for the period ended
31 March 2026
Ips Therapy Ltd
Statement of Financial Position
31 March 2026

| 31 Mar 2026
--- | ---
| £
Current assets | 5,829 |
Creditors: amounts falling due within one year | (2,533 | )
Net current assets | 3,296 |
Accruals and deferred income | (480 | )
Net assets | 2,816 |
Capital and reserves | 2,816 |

## Notes to the Financial Statements

## 1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
85 Great Portland Street
,
London
,
W1W 7LT
, England.

## 2 Average number of employees

The average number of persons employed by the company during the period was nil.
For the period ending
31 March 2026
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the
board of directors
and authorised for issue on
15 April 2026
, and are signed on behalf of the board by:

C Cresswell
Director

Company registration number:
16406418